Google and Verily reveal algorithm for diabetic eye disease screening - MedCity News

Google and Verily, Alphabet's life sciences and healthcare arm, have created a machine learning algorithm to help screen for diabetic retinopathy and diabetic macular edema, according to a Google blog post. The development of the algorithm has been a three-year project, which also involved the organizations conducting a global clinical research program focused on India. Verily has received a CE mark for the algorithm. Now, they've revealed the first real-world clinical use of the algorithm is happening at Aravind Eye Hospital in Madurai, India. At the hospital, the process works like this: Technicians use a fundus camera to take one image of each of the patient's eyes.